Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Alkem Laboratories Limited is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has increased by 2.80%
ALKEM LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | Download
ALKEM LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | Download
Alkem Laboratories Limited has informed the Exchange regarding Appointment of Mr Ashish Kumar Suresh at Senior Management Position of the Company w.e.f. October 09, 2024. | Download
Alkem Laboratories Limited has informed the Exchange regarding Appointment of Mr Ashish Kumar Suresh at Senior Management Position of the Company w.e.f. October 09, 2024. | Download
Final • Div/Share: ₹ 5
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant